The ApoA-I Milano mutation is associated with low levels of HDL-C and reduced risk of CVD (747)

Receptor Signaling: GPCRs and Beyond Butyrate activates several G-protein coupled receptors (GPCRs) that mediate its systemic effects: [7] GPR41 (FFAR3) Expressed in enteroendocrine cells, adipose tissue, and immune cells, GPR41 activation by butyrate: Stimulates GLP-1 and PYY secretion , regulating appetite and glucose metabolism Modulates adipocyte function and energy storage Influences sympathetic nervous system activity GPR43 (FFAR2) With broader expression including intestinal epithelium, immune cells, and adipocytes, GPR43 mediates: Promotes healthy inflammation responses through regulatory T cell (Treg) expansion Neutrophil chemotaxis and immune cell recruitment Insulin sensitivity improvements Intestinal barrier enhancement GPR109A (HCA2) This receptor, also known as the niacin receptor , responds to butyrate by: Supporting colonic immune balance and cellular resilience Inducing IL-18 production, which maintains epithelial integrity Promoting anti-inflammatory macrophage differentiation Immune Modulation: The Treg Connection One of butyrate's most important systemic effects involves regulatory T cell (Treg) differentiation

With many celebrities showing off significant weight loss and better bodies, thousands of Americans and people across the world are scrambling to get their hands on these meds hoping to lose some unwanted weight
What clinicians and researchers are watching now Medical teams are tracking reports linking GLP-1s to heat-related issues
While the exact mechanisms in some cases remain unclear, a triad of OS, inflammation, and functional impairment appears to be involved in the pathogenesis of many clinical conditions [1,3,8,15,24]
L., and Sun, T